New Public Perception Survey Highlights Fragmented Cancer Care Pathway in Thailand; Optimism About Digital Innovations
YouGov survey finds strong belief in value of early detection (88%) but under half screened (40%) 84% of respondents aware post-treatment care exists, 55% lack understanding of what it involves Findings show confidence in "one-stop" cancer services and cautious optimism for digital innovation BANGKOK , Sept. 10, 2025 /PRNewswire/ -- Public...
New Public Perception Survey Highlights Fragmented Cancer Care Pathway in Indonesia; Optimism About Digital Innovations
YouGov survey finds belief in value of early detection (65%) but very low screening uptake (8%) 76% of respondents aware post-treatment care exists, 58% lack understanding of what it involves Confidence in coordinated care (39%) and in 'one-stop' care (31%) among lowest in Southeast Asia JAKARTA, Indonesia, Sept. 10, 2025...
Korea Health Functional Food Association to Showcase Global Competitiveness at “Vitafoods Asia 2025”
Operating a Korea Health Functional Food Promotional Booth under the 'K-Health W.A.V.E' slogan Introduces Korea's system, research achievements, and new technologies through seminars featuring the Ministry of Food and Drug Safety and member companies SEOUL, South Korea, Sept. 10, 2025 /PRNewswire/ -- The Korea Health Functional Food Association (KHFF) will participate in "Vitafoods Asia 2025," to be held...
ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of...
SUZHOU, China, Sept. 10, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company") recently announced that its lead engineered exosome candidate, MVR-EX105 ("EX105") is featured in a poster presentation at the 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Founded in 1995, IFSO is a leading international professional organization comprising bariatric...
Cadonilimab(PD-1/CTLA-4) plus Pulocimab (VEGFR-2) Combination Therapy Shows Promising Results in IO-Resistant Non-Small Cell Lung Cancer in Oral Presentation at the 2025 WCLC
HONG KONG, Sept. 10, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that data from a Phase Ib/II clinical study evaluating the combination of cadonilimab and pulocimab (an anti-VEGFR-2 antibody) in patients with immunotherapy (IO)-resistant NSCLC were presented in a Mini Oral session at the 2025 World Conference on Lung Cancer (WCLC). This marks the first clinical data release...
Allianz Partners appoints Okan Özdemir as its new Chief Officer for Health
PARIS, Sept. 10, 2025 /PRNewswire/ -- Allianz Partners, a global leader in insurance and assistance services, is pleased to announce the appointment of Okan Özdemir as its new Chief Officer for Health and Board Member, effective September 1, 2025. In this role, Okan will report directly to Allianz Partners CEO Tomas Kunzmann. Okan...
New Public Perception Survey Highlights Fragmented Cancer Care Pathway in Malaysia; Optimism About Digital Innovations
YouGov survey finds strong belief in value of early detection (79%) but low screening uptake (25%) 82% of respondents aware post-treatment care exists, 55% lack understanding of what it involves Findings show confidence in "one-stop" cancer services and openness to digital innovation KUALA LUMPUR, Malaysia, Sept. 10, 2025 /PRNewswire/ --...
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® (kits for the preparation of gallium-68 (68Ga) gozetotide injection) to include prostate...
TCI Biotech Strengthens Global Leadership Team with Appointment of Sales VP Tony Hatori and Strategic Consultant Alan Roberts
SALT LAKE CITY, Utah, Sept. 9, 2025 /PRNewswire/ -- TCI, a global biotechnology leader in health and wellness innovation, today announced key leadership appointments to accelerate its international growth. Tony Hatori has been named Vice President of Sales, while Alan Roberts joins as Strategic Consultant for the U.S. market. These appointments underscore TCI's commitment to advancing a science-driven, asset-light,...
CAS introduces CAS IP Finder for improved intellectual property search
The AI-enhanced solution deepens search capabilities and improves user experience COLUMBUS, Ohio, Sept. 9, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, announces the introduction of CAS IP Finder, powered by STN™. This new intellectual property search solution expands on the trusted foundation of...
